BioResources

6 Radiopharmaceutical Programmes and Sites to Watch in APAC

Radioligand therapy is the one modality a region cannot buy its way into late. A vial of lutetium-177 loses half its therapeutic activity in roughly six an...

 August 18, 2026 | Analysis

5 Private Dentists in Knightsbridge for Personalized Orthodontic Treatment

Private dentists in Knightsbridge serve one of London's most affluent postcodes, yet price transparency remains surprisingly poor across the area, and veri...

 August 13, 2026 | News

Top-Rated Functional Medicine Doctors in Denver for Comprehensive Care

The challenge is real: separating genuinely trained practitioners from people marketing wellness without the science to back it up is harder than it should...

 August 11, 2026 | News

Reading the Register: What Japan's Provision Plans Actually Say

A register, not an approval list Start with the thing that is most often got wrong, including by people who should know better. The Act on the Safety of ...

 August 10, 2026 | Analysis

5 Trusted Psychiatry Practices in Los Angeles for Childhood Trauma

New patient wait times stretch for weeks, insurance coverage varies wildly, and not every provider knows how to treat trauma-related conditions like PTSD o...

 August 04, 2026 | Analysis

9 AI Drug Discovery Platforms Built in Asia-Pacific, and What They Have Actually Shipped

For most of the past decade, the only honest answer to the question of whether AI drug discovery works in Asia-Pacific was that nobody could yet know. The ...

 August 04, 2026 | Analysis

12 Funding Rounds That Show Where APAC Biotech Capital Is Going

There is a version of this story that lists twelve press releases and calls it analysis. This is not that story. Every round below has already been announc...

 July 30, 2026 | News

How Is Connected Care Reaching Patients at Home?

At the edge of this trend sit simple connected safety devices that keep patients linked to help. To see how that works in practice, learn more about home e...

 July 27, 2026 | News

7 Countries Competing to Be the Region’s Next Biomanufacturing Hub

A siting decision for a biomanufacturing facility is one of the most expensive commitments a company makes, and it is made against a fifteen to twenty year...

 July 27, 2026 | Analysis

The APAC CDMO Shortlist: 10 CDMOs to Watch Through 2028

There is a version of this list that writes itself. Rank the region’s contract manufacturers by installed litres, put Samsung Biologics at the top, a...

 July 24, 2026 | Analysis

The Technology Is Ready. Are APAC’s Regulators?

In a process-development suite in Singapore, or Hyderabad, or Songdo, a perfusion bioreactor can now run for weeks, its output feeding straight into a conn...

 July 15, 2026 | Regulatory

Innovations in Hematologic Oncology: Addressing Unmet Needs in CLL Care

Lymphocyte Type, Blood Cancer Chronic lymphocytic leukaemia (CLL) is a blood malignancy caused by an overproduction of lymphocytes in the blood, lymphatic...

 July 13, 2026 | Analysis

Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?

Scope 3 clauses, single-use plastic, water and energy intensity: the “green premium” has become the defining question for the CDMOs that built ...

 July 14, 2026 | Analysis

The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.

A control room that thinks it knows what happens next Walk the mezzanine above a modern biologics suite in Singapore, Songdo or Hyderabad and the change i...

 July 13, 2026 | Analysis


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close